Amid evolving trade dynamics in the Middle East, HaorunMed is strategically advancing its presence in the Saudi medical device market by capitalizing on a pivotal regulatory milestone. The company has successfully obtained its SFDA registration application number in 2025, with the official certification anticipated within the coming month. This achievement positions HaorunMed for expedited market entry, as Saudi authorities now permit customs clearance based solely on the registration application number—a significant advantage in the current climate.
Leveraging its early compliance with Saudi regulatory standards, HaorunMed is well-equipped to respond to urgent market demands. The company warmly invites its Saudi partners to reconnect and explore timely collaboration opportunities during this favorable approval window, reinforcing a shared commitment to advancing healthcare across the region.